Singapore - English - HSA (Health Sciences Authority)

advance healthcare pte. ltd. - ophthalmology - are sterile, preservative-free solutions in single-use dose containers, for the rehydration, lubrication and protection of the eye from dryness and irritation caused during contact lenses wear.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - sodium alginate; potassium bicarbonate - oral suspension - 100mg/1ml ; 20mg/1ml

Singapore - English - HSA (Health Sciences Authority)

sg medical pte ltd - neurology - the x8 system is intended for prescription use in the home, healthcare facility, or clinical research environment to acquire, record, transmit, and display physiological signals from adult patients. all x8 models (sp40, sp29, and xs29) acquire, record, transmit, and/or display electroencephalogram (eeg), electrooculogram (eog), electrocardiogram (ecg), and/or electromyogram (emg) signals, with optional accelerometer, acoustical, and photoplethysmographic signals. model sp29 additionally includes a nasal pressure transducer and cannula (for airflow), thoracic and abdomen respiratory effort, and pulse rate and oxyhemoglobin saturation from the finger. the x8 system only acquires and displays physiological signals; no claims are being made for analysis of the acquired signals with respect to the accuracy, precision, and reliability.

Singapore - English - HSA (Health Sciences Authority)

advanced ophthalmic innovations pte. ltd. - ophthalmology - for use in patients with medically uncontrollable glaucoma and poor surgical outcomes. this includes but is not limited to neovascular glaucoma, aphakic/ pseudophakic glaucoma, patients who have failed conventional surgery, congenital glaucoma and secondary glaucoma due to uveitis, epithelial downgrowth, etc.

Singapore - English - HSA (Health Sciences Authority)

advanced ophthalmic innovations pte. ltd. - ophthalmology - the uni®20 glaucoma implant is a glaucoma drainage device designed to treat glaucoma by regulating intraocular pressure in the patient’s eye and preventing further progression of the disease. for use in patients with primary glaucoma where medication alone may not be enough.

Singapore - English - HSA (Health Sciences Authority)

science team pte. ltd. - clinical chemistry - advanced instruments osmometers use the technique of freezing point depression to measure osmolality. osmolality is a valuable clinical tool used in the diagnosis and treatment of patients. it is a quick and effective test to help evaluate the body’s water balance or its ability to produce and concentrate urine, to investigate low sodium levels (hyponatremia), to detect the presence of toxins in the body, and to monitor the osmolality of patients undergoing osmotically active drug therapies such as mannitol, which is used to treat cerebral edema. this test is also ordered to help monitor the effectiveness of a treatment for a condition found to be adversely affecting a person’s osmolality. osmometers test the following sample types: serum, plasma and urine.

Singapore - English - HSA (Health Sciences Authority)

reckitt benckiser (singapore) pte ltd - potassium bicarbonate; sodium alginate - suspension - 200 mg/10 ml - potassium bicarbonate 200 mg/10 ml; sodium alginate 1000 mg/10 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - epirubicin hydrochloride, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - zoledronic acid monohydrate, quantity: 4.264 mg (equivalent: zoledronic acid, qty 4 mg) - injection, concentrated - excipient ingredients: sodium citrate dihydrate; mannitol; water for injections - zoledronic acid accord is indicated:,for the prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone.,for treatment of tumour-induced hypercalcaemia.,as an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pemetrexed disodium, quantity: 110.29 mg (equivalent: pemetrexed, qty 100 mg) - injection, powder for - excipient ingredients: mannitol; sodium hydroxide; hydrochloric acid - malignant pleural mesothelioma,pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer,pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.